Archive: medtech

Premium
Cancer sucks. Everyone knows someone who has been affected by this deadly disease. And while treatment has come a long way, there is still no cure. The disease kills more than 600,000 people in the United States every year. Billions of dollars have been poured into cancer drug development for decades… but to no avail.  Oncolyze, the anti-cancer biotech startup I’m introducing to you today, has some of the most promising efficacy data that…
Premium

Monogram Orthopaedics Announces an IPO

By Teddy Lyons on April 27, 2023

Great news.  Monogram Orthopaedics is going public on May 18! The company is going to list on the Nasdaq under the ticker MGRM.  The company will go public at $7.25 per share. But don’t worry if this price seems low. Monogram recently completed a…

Three Ways 2023 Can Benefit Investors

By Allison Brickell on December 28, 2022

We’re just a few days away from the start of a new year. So I’m reflecting on all the things that have happened in 2022… and all the things that may happen in 2023.  2022 was a rough year for the stock, startup and crypto markets.
Premium
Note: This recommendation was co-authored by KingsCrowd Investment Research Analyst Teddy Lyons. I prefer to stay as far away from hospitals as possible.  Don’t get me wrong. I appreciate hospitals. But I also know that hospitals are…
Premium

New Pick: Breast Cancer Screening Tech That Saves Lives

By Andy Gordon on October 20, 2022

Note: This recommendation was co-authored by KingsCrowd Investment Research Associate Inez Sanjaya. The first time I learned that mammograms were incredibly painful was the first time Cecily got one after we got married. I guess this is something mothers…
Premium
I love companies that make me think, “Why didn’t I think of that?” These are almost never pure technology plays because the technology is already there. It’s merely waiting for a clever company with a clever idea to make profitable use of it.  The technology-in-waiting here…
Things are only impossible until they are not.  These inspiring words were spoken by Captain Jean-Luc Picard, a character from “Star Trek: The Next Generation.” And I’m not quoting him just because I like Star Trek. (Though I really do.) Star Trek shows us…
Premium
Our broken healthcare system has no shortage of startups trying to fix big stubborn problems.  The opportunities are plentiful. That’s the upside. But the reason there is so much opportunity is that healthcare in the U.S. has been so resistant to change. And that’s the downside. …
Premium
My first and last surgery was a couple of years ago. I’m glad I didn’t know then what I know now. My surgeon told me the risks were low and a favorable outcome was high. He didn’t mention that he’d be using instruments that would burn or at…
Premium
Medical technology — or medtech — is an incredibly innovative sector. From wearables to robotic surgeries to non-invasive health monitoring solutions, there are tons of ways that medtech is advancing and disrupting itself.  Early Investing co-founder Andy Gordon should know. He’s recommended many different medtech startups…
Premium
In a slightly less broken world, Enosi Life Sciences would not exist as is. Enosi is a tiny drug research and development company. And that is the only ordinary-sounding thing about it. Its technology is not ordinary. Its rockstar founders are far from ordinary. And its…
Premium

Startup Deals for Accredited Investors Only

By Vin Narayanan on March 15, 2022

Early Investing co-founder Andy Gordon and I recently met with several founders in Los Angeles and San Francisco. We’re looking for startups that you might be interested in investing in. The startups we looked at included cutting-edge robotics companies, medtech disruptors and moonshots that could change…
Premium

Take Advantage of the Golden Age of Medtech Investing

By Vin Narayanan on February 8, 2022

A basic market inefficiency has created a massive opportunity for startup investors interested in medical technology and drug development startups. And angel investors savvy enough to understand what’s going on have a rare opportunity to invest in medtech startups with massive upside that have been significantly…
Premium
Lots of sectors are broken: banking, housing, education, day care and infrastructure. But none of these are as broken as the physical disability space. Fewer than one out of five arm amputees who need prosthetics actually use them. Available prosthetics are too heavy, clumsy and uncomfortable. They’re super…

Look Beyond Big Tech Investments

By Allison Brickell on October 13, 2021

Last Monday, Facebook experienced an outage that lasted for about six hours. Users couldn’t access Facebook, Messenger, Instagram, Whatsapp or OculusVR.  The effects were felt across the world. Suddenly, everyone who relied on Facebook or WhatsApp for communication was left in a lurch. Even…
Premium

Illusio’s Future Remains Bright

By Andy Gordon on September 23, 2021

I first presented Illusio to First Stage Investor subscribers in April 2020. It was interesting timing, to say the least. We were finally realizing just how serious COVID-19 was. It certainly affected Illusio… and not in the best of…